Impact of the COVID-19 pandemic on hepatitis C outcomes at a health-system specialty pharmacy

BACKGROUND: The goal of hepatitis C virus (HCV) treatment is to cure the patient of the infection, defined as a nondetectable HCV RNA at least 12 weeks after treatment completion, or sustained virologic response (SVR). The COVID-19 pandemic has presented new barriers to care in the treatment of pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Cooper, Megan Pendley, Foley, Heather, Damico, David, Wright, Maribeth, Rhudy, Christian, Schadler, Aric, Platt, Thom
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2022
Materias:
Research Brief
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372976/
https://www.ncbi.nlm.nih.gov/pubmed/35621721
http://dx.doi.org/10.18553/jmcp.2022.28.6.667

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372976/
https://www.ncbi.nlm.nih.gov/pubmed/35621721
http://dx.doi.org/10.18553/jmcp.2022.28.6.667

Ejemplares similares